A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe.
from Reuters: Health News https://ift.tt/2zWkVz5
No comments:
Post a Comment